Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Management of AL Amyloidosis

GRACE

S. Rajeeve

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

Diagnosing AL Amyloidosis

GRACE

S. Rajeeve

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Signs and Symptoms of AL Amyloidosis

GRACE

S. Rajeeve

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Susanibar-Adaniya

AL Amyloidosis Treatment Updates

Yale Cancer Center

T. Parker

Emerging Treatment Options for AL Amyloidosis

GRACE

S. Rajeeve

Chapter 2: Unmet Needs in Amyloidosis Diagnosis and Care - Vaishali …

Springer Healthcare IME

V. Sanchorawala

The Role of SCT Amidst Emerging Therapies in the Treatment of AL Amy…

Rush University Medical Center

V. Sanchorawala

Renal AL Amyloid

Yale Cancer Center

R. Luciano

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed Stage…

Insights from 2023 ASH Annual Meeting

E. Kastritis